Endocrine and anti-tumour effects in breast cancer patients treated neo-adjuvantly with the aromatase inhibitor, letrozole

被引：0
|
作者：
Miller, WR [1 ]
Dixon, JM [1 ]
Telford, J [1 ]
Marson, L [1 ]
Bellamy, C [1 ]
Kurian, K [1 ]
MacFarlane, L [1 ]
Anderson, TJ [1 ]
机构：
[1] Western Gen Hosp, Edinburgh Breast Unit, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P304
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [31] The differential anti-tumour effects of zoledronic acid in breast cancer - evidence for a role of the activin signaling pathway
    Wilson, Caroline
    Ottewell, Penelope
    Coleman, Robert E.
    Holen, Ingunn
    BMC CANCER, 2015, 15
  • [32] The differential anti-tumour effects of zoledronic acid in breast cancer – evidence for a role of the activin signaling pathway
    Caroline Wilson
    Penelope Ottewell
    Robert E Coleman
    Ingunn Holen
    BMC Cancer, 15
  • [33] Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer
    Howell, A
    DeFriend, DJ
    Robertson, JFR
    Blamey, RW
    Anderson, L
    Anderson, E
    Sutcliffe, FA
    Walton, P
    BRITISH JOURNAL OF CANCER, 1996, 74 (02) : 300 - 308
  • [34] Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells
    Aleksandra Filipović
    Ylenia Lombardo
    Monica Fronato
    Joel Abrahams
    Eric Aboagye
    Quang-De Nguyen
    Barbara Borda d’Aqua
    Anne Ridley
    Andrew Green
    Emad Rahka
    Ian Ellis
    Chiara Recchi
    Natasa Przulj
    Anida Sarajlić
    Jean-Rene Alattia
    Patrick Fraering
    Mahendra Deonarain
    R. Charles Coombes
    Breast Cancer Research and Treatment, 2014, 148 : 455 - 462
  • [35] Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: A pilot study for breast cancer prevention
    Harper-Wynne, C
    Ross, G
    Sacks, N
    Salter, J
    Nasiri, N
    Iqbal, J
    A'Hern, R
    Dowsett, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (07) : 614 - 621
  • [36] The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
    Coleman, R. E.
    Winter, M. C.
    Cameron, D.
    Bell, R.
    Dodwell, D.
    Keane, M. M.
    Gil, M.
    Ritchie, D.
    Passos-Coelho, J. L.
    Wheatley, D.
    Burkinshaw, R.
    Marshall, S. J.
    Thorpe, H.
    BRITISH JOURNAL OF CANCER, 2010, 102 (07) : 1099 - 1105
  • [37] Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: A phase I study
    Johannessen, DC
    Engan, T
    DiSalle, E
    Zurlo, MG
    Paolini, J
    Ornati, G
    Piscitelli, G
    Kvinnsland, S
    Lonning, PE
    CLINICAL CANCER RESEARCH, 1997, 3 (07) : 1101 - 1108
  • [38] The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
    R E Coleman
    M C Winter
    D Cameron
    R Bell
    D Dodwell
    M M Keane
    M Gil
    D Ritchie
    J L Passos-Coelho
    D Wheatley
    R Burkinshaw
    S J Marshall
    H Thorpe
    British Journal of Cancer, 2010, 102 : 1099 - 1105
  • [39] Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
    Brassard, Maryse
    Neraud, Barbara
    Trabado, Severine
    Salenave, Sylvie
    Brailly-Tabard, Sylvie
    Borget, Isabelle
    Baudin, Eric
    Leboulleux, Sophie
    Chanson, Philippe
    Schlumberger, Martin
    Young, Jacques
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09): : 2741 - 2749
  • [40] Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry
    Pavlik, Tomas
    Majek, Ondrej
    Muzik, Jan
    Koptikova, Jana
    Slavicek, Lubomir
    Finek, Jindrich
    Feltl, David
    Vyzula, Rostislav
    Dusek, Ladislav
    BMC PUBLIC HEALTH, 2012, 12
12345